COPD Archives - Express Pharma

Real-world data backs anti-IL-5 use in COPD with comorbid asthma

Lupin collaborates with Honeywell, plans for HFO technology in Inhalers

GSK’s Nucala highlights IL-5 inhibition in reducing COPD exacerbations in eosinophilic patients: GlobalData

COPD diagnosed prevalent cases across 7MM to reach 38.02 million in 2033, forecasts GlobalData

EMA approval of Sanofi/Regeneron’s Dupixent fills biologic gap in COPD: GlobalData

AstraZeneca receives CDSCO approval to market its inhalation aerosol

Lupin partners with Cost Plus Drugs, COPD Foundation

Lupin receives approval from TGA Australia for Tiotropium dry powder

Lupin signs MoU with Maha Govt to combat cardiovascular diseases and COPD

Zydus gets USFDA approval for Roflumilast Tablets, 250 mcg